Evidence map›Paper›PMID 41179894›Full record

ArticleFrontiers in medicine2025

Correction: Harnessing the promises of cell therapy, gene therapy, and regenerative medicine in Québec, Canada.

Jean-Sébastien Delisle, Diane Fournier, Kim Santerre, Samuel Rochette, Ma'n H Zawati, Maude Dumont-Lagacé, Simon Turcotte, Jason Robert Guertin, Patrick Vermette, Jacques P Tremblay and 7 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Jean-Sébastien DelisleCentre de recherche de l'Hôpital Maisonneuve-Rosemont, Montreal, QC, Canada.
Diane FournierTransfusion Medicine, Héma-Québec, Montreal, QC, Canada.
Kim SanterreQuébec Cell, Tissue and Gene Therapy Network, Montreal, QC, Canada.
Samuel RochetteTransfusion Medicine, Héma-Québec, Montreal, QC, Canada.
Ma'n H ZawatiQuébec Cell, Tissue and Gene Therapy Network, Montreal, QC, Canada.
Maude Dumont-LagacéTransfusion Medicine, Héma-Québec, Montreal, QC, Canada.
Simon TurcotteQuébec Cell, Tissue and Gene Therapy Network, Montreal, QC, Canada.
Jason Robert GuertinQuébec Cell, Tissue and Gene Therapy Network, Montreal, QC, Canada.
Patrick VermetteQuébec Cell, Tissue and Gene Therapy Network, Montreal, QC, Canada.
Jacques P TremblayQuébec Cell, Tissue and Gene Therapy Network, Montreal, QC, Canada.
Maxime ParisottoadMare BioInnovations, Montreal, QC, Canada.
Christian BeauséjourQuébec Cell, Tissue and Gene Therapy Network, Montreal, QC, Canada.
Jean-François GélinasQuébec Cell, Tissue and Gene Therapy Network, Montreal, QC, Canada.
Louisa PetropoulosCentre C3i Inc., Montreal, QC, Canada.
Natasha KekreDivision of Hematology, Department of Medicine, The Ottawa Hospital, Ottawa, ON, Canada.
Stéphanie MichaudBioCanRx, Ottawa, ON, Canada.
Mélanie DieudéAxe immunopathologie, Centre de recherche du Centre hospitalier de l'Université de Montréal, Montreal, QC, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fmed.2025.1581058.].

Indexed as

biological drug approvalcell and tissue manufacturingeconomic evaluationethicsimmune effector cell immunotherapyresearch funding

Identifiers

PMID41179894
PMCPMC12576915

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.